Indian Journal of Ophthalmology

CASE REPORT
Year
: 2019  |  Volume : 67  |  Issue : 5  |  Page : 696--698

Focal choroidal excavation: Cause or effect?


Raj C Shah, Mahesh Gopalakrishnan, Anubhav Goyal, Giridhar Anantharaman, Abhishek Sethia 
 Department of Vitreo-Retina, Giridhar Eye Institute, Ponneth Temple Road, Kadavanthra, Cochin, Kerala, India

Correspondence Address:
Dr. Mahesh Gopalakrishnan
Giridhar Eye Institute, Ponneth Temple Road, Kadavanthra, Cochin, Kerala - 682 020
India

Abstract

We report the imaging characteristics of focal choroidal excavation (FCE) and associated choroidal neovascular membrane (CNVM) and interpret the probable etiopathogenesis of FCE through findings in four patients detected by spectral-domain optical coherence tomography (SD-OCT). FCE was found as an acquired entity in two of our cases subsequent to treatment of CNVM, whereas in the two other cases FCE was pre-existing. Furthermore, association of FCE with pachychoroid spectrum is reaffirmed through this case series.



How to cite this article:
Shah RC, Gopalakrishnan M, Goyal A, Anantharaman G, Sethia A. Focal choroidal excavation: Cause or effect?.Indian J Ophthalmol 2019;67:696-698


How to cite this URL:
Shah RC, Gopalakrishnan M, Goyal A, Anantharaman G, Sethia A. Focal choroidal excavation: Cause or effect?. Indian J Ophthalmol [serial online] 2019 [cited 2024 Mar 29 ];67:696-698
Available from: https://journals.lww.com/ijo/pages/default.aspx/text.asp?2019/67/5/696/256661


Full Text



Focal choroidal excavation (FCE) is a concavity in the choroid of unknown etiology, occurring without any adjacent scleral abnormality or ectasia, and characterized by good visual acuity and shows minimal changes over time. It was first described with time-domain optical coherence tomography (OCT) by Jampol et al. in 2006.[1]

FCE is believed by most authors to be a congenital condition, though its etiopathogenesis is yet unclear. FCE is detected primarily as an OCT finding. It is frequently associated with pachychoroid diseases, including central serous chorioretinopathy (CSCR), choroidal neovascular membrane (CNV) and polypoidal choroidal vasculopathy (PCV). Although FCE is classically thought to be congenital, acquired FCE forms possibly exist.[2]

To our knowledge, the known reports of acquired FCE following CNVM was by Lee et al.,[2] where a small choroidal excavation developed during CNV scarring changes in age-related macular degeneration, whereas another single case report by Hashimoto et al.[3] was secondary to multifocal choroiditis.

Here, we report four cases of FCE associated with CNVM, including two of acquired FCE post treatment of CNVM, one with pre-existing FCE, which later increased in size over time after treatment of CNVM, and one where the FCE lesion remained stable over the follow-up period.

 Case Reports



Case 1

A 17-year-old female presented with metamorphopsia and blurred vision in right eye (OD) since 1 week. Her best corrected visual acuity (BCVA) was 6/9;N8 in OD and 6/6;N6 in left eye (OS). Clinical examination revealed findings suggestive of choroidal neovascular membrane (CNVM). Her spectral-domain optical coherence tomography (SD-OCT) showed an active Type 2 CNVM associated with a FCE, which was confirmed by fundus fluorescein angiography (FFA). She was treated with multiple intravitreal antiVEGF injections. At her follow-up visits there was significant CNVM resolution, but FCE was progressively increasing in depth, as measured from a horizontal line drawn at the level of RPE to the inner margin of FCE, from 121 μm to 256 μm over the period of 2 years, possibly due to the contraction of the underlying scar [Figure 1].{Figure 1}

Case 2

A 21-year-old male presented with distortion of vision in OS noted accidently since 8 days with BCVA of 6/6;N6 in both eyes. Fundus examination revealed an extrafoveal grayish membrane with overlying hemorrhages. Enhanced depth imaging showed pachychoroid with thickness of 443 μm. SD-OCT revealed CNVM associated with FCE. AntiVEGF monotherapy was given with complete resolution of CNVM, but the FCE remained stable in size and configuration during subsequent follow-ups. Final BCVA was maintaining to 6/6; N6 in both the eyes [Figure 2].{Figure 2}

Case 3

A 48-year-old female presented to us with blurring and distortion of vision in OS since 2 weeks. Her BCVA was 6/6; N6 in OD and 6/24;N10 in OS at presentation. Fundus examination showed an extrafoveal CNVM. Based on multimodal imaging including SD-OCT and FFA, patient was diagnosed to have type-2 CNVM with subfoveal choroidal thickness of 505 μm. She was also treated with antiVEGF monotherapy on pro re nata (PRN) basis and had multiple recurrences over 5 years. Interestingly, she developed FCE at the site of resolved CNVM scar, during 23 months of treatment, which progressively increased from 85 μm to 154 μm in depth over the subsequent follow-ups. We report this as a case of acquired FCE secondary to CNVM [Figure 3].{Figure 3}

Case 4

A 46-year-old male patient presented to us with blurring of vision OS since 2 months. His BCVA was 6/6, N6 in OD and 6/12, N8 in OS at presentation. Fundus examination of OS showed an irregular elevated, yellowish-white choroidal lesion with welldefined geographic borders involving the inferior macula with areas of subretinal hemorrhage at and above the fovea suggestive associated choroidal neovascular membrane. SD-OCT showed a dense hyper-reflective choroidal mass with significant widening of the choroidal layers. B-scan ultrasonography revealed high-spike echoes through the lesion suggesting choroidal osteoma. FFA in that area showed staining conforming to the diagnosis of choroidal osteoma with a secondary CNVM. Patient underwent treatment with multiple antiVEGF injections and standard fluence photodynamic therapy (PDT). The patient developed an acquired FCE after 17 months of treatment [Figure 4].{Figure 4}

 Discussion



Several authors have postulated that FCE lesions are congenital choroidal abnormalities related to developmental defects or some other type of focal structural defect within the choroid.[1],[2],[4],[5]

Ellabban et al.[4] and Hashimoto et al.[3] suggested, the OCT finding of an “unusual hyper-reflective tissue” beneath some FCE lesions could represent scarring of choroidal connective tissue from a previous inflammatory process. Presumably, scar contraction could draw the choroid and RPE toward the sclera producing FCE. Our cases support the above alternative etiopathogenesis leading to an acquired subtype of FCE in addition to the known congenital form of FCE complicated secondarily by CNVM/CSCR.

The occurrence of FCE in eyes with increased choroidal thickness has been noted by several investigators.[6],[7] Our cases also had increased choroidal thickness with pachyvessel/s adjacent to the excavation, reaffirming the fact that FCE is associated with the pachychoroid spectrum.

 Conclusion



To conclude, FCE is an OCT-based diagnosis. FCE is known to be associated with pachychoroid spectrum of diseases, with known associations being CSCR and CNVM. Origin of FCE can be of two types: congenital and acquired. The significance of the acquired variety remains unknown until more such cases are reported. Periodic monitoring of such cases is of importance to detect and treat any of the known associations.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

1Jampol LM, Shankle J, Schroeder R, Tornambe P, Spaide RF, Hee MR. Diagnostic and therapeutic challenges. Retina 2006;26:1072-6.
2Lee CS, Woo SJ, Kim YK, Hwang DJ, Kang HM, Kim H, et al. Clinical and spectral-domain optical coherence tomography findings in patients with focal choroidal excavation. Ophthalmology 2014;121:1029-35.
3Hashimoto Y, Saito W, Noda K, Ishida S. Acquired focal choroidal excavation associated with multiple evanescent white dot syndrome: Observations at onset and a pathogenic hypothesis. BMC Ophthalmol 2014;14:135.
4Ellabban AA, Tsujikawa A, Ooto S, Yamashiro K, Oishi A, Nakata I, et al. Focal choroidal excavation in eyes with central serous chorioretinopathy. Am J Ophthalmol 2013;156:673-83.
5Shinojima A, Kawamura A, Mori R, Yuzawa M. Morphologic features of focal choroidal excavation on spectral domain optical coherence tomography with simultaneous angiography. Retina 2014;34:1407-14.
6Margolis R, Mukkamala SK, Jampol LM, Spaide RF, Ober MD, Sorenson JA, et al. The expanded spectrum of focal choroidal excavation. Arch Ophthalmol 2011;129:1320-1325.
7Chung H, Byeonsh SH, Freund KB. Focal choroidal excavation and its association with pachychoroid spectrum disorders: A review of the literature and multimodal imaging findings. Retina 2017;37:199-221.